{"entity":{"id":"dermasensor-inc","kind":"company","name":"DermaSensor","aka":[],"tldr":"DermaSensor makes a handheld device that shines light into a worrying skin spot and uses a trained algorithm to say whether it should be looked at more closely for skin cancer. It is meant for family doctors rather than skin specialists.","summary":"DermaSensor Inc., of Miami, Florida, was founded in 2009, according to the company, by Maurice Ferre and Christopher Dewey, using elastic scattering spectroscopy invented by Irving Bigio of Boston University. Its wireless handheld device measures light reflectance from a skin lesion and an algorithm compares the signature with lesions of known pathology to assess the risk of the three common skin cancers. The company reports FDA De Novo clearance in early 2024 with US launch in mid-2024, a CE mark under the MDD and later a Class IIb CE mark under the MDR announced in June 2026 with an NHS collaboration, and a German launch in September 2026. A post-market surveillance study (NCT06666790) evaluates the sensitivity of the device and investigators on lesions concerning for melanoma. In October 2025 it raised 16 million US dollars in Series B funding, which it said brought total investment to 43 million US dollars, and in September 2026 it announced a further 5 million US dollars with a public round on Wefunder. Its first registered cancer study, NCT06666790, was posted on ClinicalTrials.gov in October 2024.","asOf":"2026-10-29","links":[{"label":"Official website","url":"https://www.dermasensor.com/"},{"label":"Company story and timeline","url":"https://www.dermasensor.com/our-story/"},{"label":"Series B release, October 2025","url":"https://www.dermasensor.com/news/dermasensor-secures-16m-to-scale-ai-powered-skin-cancer-detection-in-primary-care/"},{"label":"ClinicalTrials.gov: DermaSensor post-market surveillance study (NCT06666790)","url":"https://clinicaltrials.gov/study/NCT06666790"}],"tags":[],"related":[],"cancers":["melanoma","basal-cell-carcinoma","cutaneous-scc","skin-cancer"],"sections":["diagnostics","early-detection"],"technologies":["skin-cancer-screening","optical-imaging"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Sensitivity and specificity figures quoted on the company site (96 to 100 per cent sensitivity, specificity up to 77 per cent for pigmented lesions) are the company's summary of its studies and are not recorded as findings here; the studies were not read.","The September 2026 5 million US dollar raise is from a release headline listed on the company's press page; the release body was not read, so no funding row is recorded for it.","Read on 29 October 2026.","The id is dermasensor-inc because src/data/software.ts already has a product record with id dermasensor for the device itself."],"hq":"Miami, FL","country":"US","companyType":"devices","website":"https://www.dermasensor.com/","founded":2009,"stage":"growth","investors":[],"funding":[{"round":"Series B","year":2025,"amountUsd":16000000,"source":"https://www.dermasensor.com/news/dermasensor-secures-16m-to-scale-ai-powered-skin-cancer-detection-in-primary-care/","note":"Existing investors with Pier 70 Ventures, Kern Venture Group, GenHenn Capital and an undisclosed strategic investor; the company states total investment of 43 million US dollars"}]},"route":"/companies/dermasensor-inc/","neighbours":{"cancer":[{"id":"basal-cell-carcinoma","kind":"cancer","name":"Basal cell carcinoma","route":"/cancers/basal-cell-carcinoma/"},{"id":"cutaneous-scc","kind":"cancer","name":"Cutaneous squamous cell carcinoma","route":"/cancers/cutaneous-scc/"},{"id":"melanoma","kind":"cancer","name":"Melanoma","route":"/cancers/melanoma/"},{"id":"skin-cancer","kind":"cancer","name":"Skin cancer (all types)","route":"/cancers/skin-cancer/"}],"section":[{"id":"diagnostics","kind":"section","name":"Diagnostics & Biomarkers","route":"/fronts/diagnostics/"},{"id":"early-detection","kind":"section","name":"Early Detection & Screening","route":"/fronts/early-detection/"}],"technology":[{"id":"optical-imaging","kind":"technology","name":"Optical & fluorescence imaging","route":"/technologies/optical-imaging/"},{"id":"skin-cancer-screening","kind":"technology","name":"Skin cancer screening (visual skin examination)","route":"/technologies/skin-cancer-screening/"}]}}